PACS logo

PACS Group, Inc. Stock Price

NYSE:PACS Community·US$6.8b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author

PACS Share Price Performance

US$43.27
30.37 (235.43%)
US$49.67
Fair Value
US$43.27
30.37 (235.43%)
12.9% undervalued intrinsic discount
US$49.67
Fair Value
Price US$43.27
AnalystConsensusTarget US$49.67

PACS Community Narratives

·
Fair Value US$49.67 12.9% undervalued intrinsic discount

Aging Demographics And Facility Turnarounds Will Drive Stronger Post Acute Care Performance

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Trending Discussion

Updated Narratives

PACS logo

PACS: Q1 Execution And 2026 Outlook Will Drive Repricing Potential

Fair Value: US$49.67 12.9% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record and fair value.

1 Risk
3 Rewards

PACS Group, Inc. Key Details

US$5.4b

Revenue

US$4.5b

Cost of Revenue

US$910.7m

Gross Profit

US$666.9m

Other Expenses

US$243.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
1.54
16.76%
4.49%
28.1%
View Full Analysis

About PACS

Founded
2013
Employees
47455
CEO
Jason Murray
WebsiteView website
pacs.com

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Recent PACS News & Updates

Seeking Alpha Jul 12

PACS Group: The Facility Maturation Playbook Works, But It's Already Priced In

Summary PACS Group demonstrates strong operational momentum, with gross and operating margins reaching 18.3% and 9.7%, respectively. PACS is expanding aggressively, acquiring 34 new facilities and projecting 8% revenue growth in 2026, but faces material governance and regulatory risks. My discounted cash flow analysis values PACS at $43.07 per share, closely matching its current price, supporting a neutral Hold rating. Any resolution of legal and compliance overhangs could unlock significant upside, but current risk-reward appears balanced. Read the full article on Seeking Alpha

Recent updates

No updates